| Paula Suzanne Ginter, MD | |
|
1275 York Ave Dept Of, New York, NY 10065-6007 | |
| (212) 639-6780 | |
| Not Available |
| Full Name | Paula Suzanne Ginter |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 14 Years |
| Location | 1275 York Ave Dept Of, New York, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033433578 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 272742-01 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Long Island Community Hospital | Patchogue, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
Hard to Treat Diseases (HTDS.PK) Mellow Hope, an operating subsidiary of HTDS, is pleased to report that its clinical trial is currently being processed.
A new study published on the preprint server bioRxiv* in September 2020 reports the use of artificial intelligence (AI) to identify an invariant or universal host immune response found in all viral pandemics so far. The association of this response with severe COVID-19 phenotypes indicates a new understanding of the human immune response in viral pandemics.
The combination of three complementary measures to eradicate tiger mosquitos - avoid having stagnant water, using insecticides to eliminate larvae and adults, and removing rubbish - reduces more than half the number of tiger mosquitos, according to a research coordinated by researchers at Universitat Autonoma de Barcelona.
Global ophthalmic device company OptiMedica Corp. has announced that its Catalys Precision Laser System will be featured as part of four clinical presentations at the American Academy of Ophthalmology annual meeting in Chicago on October 16, 17 and 18.
› Verified 9 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Hard to Treat Diseases (HTDS.PK) Mellow Hope, an operating subsidiary of HTDS, is pleased to report that its clinical trial is currently being processed.
A new study published on the preprint server bioRxiv* in September 2020 reports the use of artificial intelligence (AI) to identify an invariant or universal host immune response found in all viral pandemics so far. The association of this response with severe COVID-19 phenotypes indicates a new understanding of the human immune response in viral pandemics.
The combination of three complementary measures to eradicate tiger mosquitos - avoid having stagnant water, using insecticides to eliminate larvae and adults, and removing rubbish - reduces more than half the number of tiger mosquitos, according to a research coordinated by researchers at Universitat Autonoma de Barcelona.
Global ophthalmic device company OptiMedica Corp. has announced that its Catalys Precision Laser System will be featured as part of four clinical presentations at the American Academy of Ophthalmology annual meeting in Chicago on October 16, 17 and 18.
› Verified 9 days ago
| Entity Name | New York Queens Medicine And Surgery, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003114851 PECOS PAC ID: 4082883673 Enrollment ID: O20110817000163 |
News Archive
Hard to Treat Diseases (HTDS.PK) Mellow Hope, an operating subsidiary of HTDS, is pleased to report that its clinical trial is currently being processed.
A new study published on the preprint server bioRxiv* in September 2020 reports the use of artificial intelligence (AI) to identify an invariant or universal host immune response found in all viral pandemics so far. The association of this response with severe COVID-19 phenotypes indicates a new understanding of the human immune response in viral pandemics.
The combination of three complementary measures to eradicate tiger mosquitos - avoid having stagnant water, using insecticides to eliminate larvae and adults, and removing rubbish - reduces more than half the number of tiger mosquitos, according to a research coordinated by researchers at Universitat Autonoma de Barcelona.
Global ophthalmic device company OptiMedica Corp. has announced that its Catalys Precision Laser System will be featured as part of four clinical presentations at the American Academy of Ophthalmology annual meeting in Chicago on October 16, 17 and 18.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paula Suzanne Ginter, MD 1275 York Ave Dept Of, New York, NY 10065-6007 Ph: (212) 639-6780 | Paula Suzanne Ginter, MD 1275 York Ave Dept Of, New York, NY 10065-6007 Ph: (212) 639-6780 |
News Archive
Hard to Treat Diseases (HTDS.PK) Mellow Hope, an operating subsidiary of HTDS, is pleased to report that its clinical trial is currently being processed.
A new study published on the preprint server bioRxiv* in September 2020 reports the use of artificial intelligence (AI) to identify an invariant or universal host immune response found in all viral pandemics so far. The association of this response with severe COVID-19 phenotypes indicates a new understanding of the human immune response in viral pandemics.
The combination of three complementary measures to eradicate tiger mosquitos - avoid having stagnant water, using insecticides to eliminate larvae and adults, and removing rubbish - reduces more than half the number of tiger mosquitos, according to a research coordinated by researchers at Universitat Autonoma de Barcelona.
Global ophthalmic device company OptiMedica Corp. has announced that its Catalys Precision Laser System will be featured as part of four clinical presentations at the American Academy of Ophthalmology annual meeting in Chicago on October 16, 17 and 18.
› Verified 9 days ago
Dr. Phillip Kaplan, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 325 N End Ave, 10-k, New York, NY 10282 Phone: 212-945-0869 Fax: 212-945-0869 | |
Dr. Iris Teo, Pathology Medicare: Not Enrolled in Medicare Practice Location: 504 E 89th St, New York, NY 10128 Phone: 646-535-5553 | |
Dr. Alexander K Lyashchenko, Pathology Medicare: Not Enrolled in Medicare Practice Location: 8 Magaw Pl Apt 24b, New York, NY 10033 Phone: 917-463-9183 | |
Alexandra Budhai, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1275 York Ave, New York, NY 10065 Phone: 212-639-2000 | |
Dr. Farshad Shafizadeh, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 461 Park Ave S, 5th Floor, New York, NY 10016 Phone: 212-777-8566 Fax: 646-536-8738 | |
Narasimhan P Agaram, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1275 York Ave, New York, NY 10065 Phone: 212-639-2000 | |
Margaret Brandwein-weber, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1000 Tenth Avenue, New York, NY 10019 Phone: 212-523-8641 Fax: 212-523-7232 |